Abstract
Statins display numerous effects independent of their well described lipid-lowering effect that may be of potential benefit in preventing vascular injury and ischemic vascular events. These effects may both prevent and improve vessel wall abnormalities. We review the current literature to provide support that statins may have a modifying effect on the vasculopathy, fibrosis and immune dysregulation observed in systemic sclerosis.
Keywords: Systemic sclerosis, scleroderma, statins, vasculopathy, tissue fibrosis
Letters in Drug Design & Discovery
Title: Inhibition of Geranyl-Geranyl Prenylation by Statins: A Novel Model of Disease Modification of Systemic Sclerosis
Volume: 3 Issue: 3
Author(s): Chris T. Derk
Affiliation:
Keywords: Systemic sclerosis, scleroderma, statins, vasculopathy, tissue fibrosis
Abstract: Statins display numerous effects independent of their well described lipid-lowering effect that may be of potential benefit in preventing vascular injury and ischemic vascular events. These effects may both prevent and improve vessel wall abnormalities. We review the current literature to provide support that statins may have a modifying effect on the vasculopathy, fibrosis and immune dysregulation observed in systemic sclerosis.
Export Options
About this article
Cite this article as:
Derk T. Chris, Inhibition of Geranyl-Geranyl Prenylation by Statins: A Novel Model of Disease Modification of Systemic Sclerosis, Letters in Drug Design & Discovery 2006; 3 (3) . https://dx.doi.org/10.2174/157018006776286998
DOI https://dx.doi.org/10.2174/157018006776286998 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design
Current Rheumatology Reviews Relaxin as a Cardiovascular Drug: A Promise Kept
Current Drug Safety ADAM17 as a Therapeutic Target in Multiple Diseases
Current Pharmaceutical Design Relaxin: New Functions for an Old Peptide
Current Protein & Peptide Science The Idiopathic Interstitial Pneumonias and Connective Tissue Disease-Associated Interstitial Lung Disease
Current Rheumatology Reviews Transforming Growth Factor-β (TGF-β ) and its Role in the Pathogenesis of Systemic Sclerosis: A Novel Target for Therapy?
Recent Patents on Inflammation & Allergy Drug Discovery New Insights into HLA-G and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Current Treatment of the Pulmonary Arterial Hypertension
Current Respiratory Medicine Reviews Haematopoietic Stem Cell Gene Therapy to Treat Autoimmune Disease
Current Stem Cell Research & Therapy Furocoumarins in Medicinal Chemistry. Synthesis, Natural Occurrence and Biological Activity
Current Medicinal Chemistry Aging and Systemic Lupus Erythematosus - Immunosenescence and Beyond
Current Aging Science The Gut Mucosa as a Site for Induction of Regulatory T-Cells
Current Pharmaceutical Design Heat Shock Proteins: Therapeutic Perspectives in Inflammatory Disorders
Recent Patents on Inflammation & Allergy Drug Discovery The Molecular Basis of the Interplay between Endothelin-1 and Nitric Oxide and its Relevance for Atherosclerosis and Arterial and Pulmonary Hypertension
Vascular Disease Prevention (Discontinued) Statins Therapy may Change a Course of Lung Fibrosis and Pulmonary Hypertension: A New Indication for Therapy or Just “Statinomania”?
Current Respiratory Medicine Reviews Inflammation, High Density Lipoprotein and Endothelium
Current Medicinal Chemistry Noninvasive Diagnosis of Chemotherapy Related Cardiotoxicity
Current Cardiology Reviews Arthropathy in Patients with CREST Variant Scleroderma
Current Rheumatology Reviews Key miRNAs in Modulating Aging and Longevity: A Focus on Signaling Pathways and Cellular Targets
Current Molecular Pharmacology Use of Systemic Proteasome Inhibition as an Immune-Modulating Agent in Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets